RemeGen Biosciences
Kevin Wait has a diverse work experience in the field of clinical operations and project management. Kevin is presently working as an Associate Director of Global Clinical Operations at RemeGen Biosciences since June 2023. Prior to this, they served as a Senior Manager of Clinical Operations at Horizon from April 2022 to May 2023. Before that, they gained significant experience at Atlantic Research Group, where they held multiple roles including Enterprise Project Manager from June 2016 to November 2021, Project Manager from May 2013 to May 2016, Associate Project Manager from May 2012 to May 2013, Project Analyst from March 2010 to May 2012, and Trial Site Manager from April 2007 to March 2010. Kevin started their career as a Pharmacology Departmental Technician at A.T. Still University in 2004.
Kevin Wait attended Truman State University where they obtained a Bachelor of Science degree in Biology and Chemistry. In 2008, they obtained a Regulatory Affairs Certification from the Regulatory Affairs Professionals Society (RAPS).
This person is not in any teams
This person is not in any offices
RemeGen Biosciences
1 followers
RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.